SLC6A3 and attention deficit-hyperactivity disorder: The implications of the prominent role for 5-HT1B receptors in serotonin-dopamine interactions in DAT KO mice identified in these experiments is considered for the potential to develop non-psychostimulant therapeutics the treatment of ADHD.